Medtronic (NYSE: MDT ) posted solid first-quarter earnings last month -- revenue climbed 5% year over year to $4.27 billion, while non-generally accepted accounting principles diluted earnings per share rose 6% to $0.93.
In an attempt to offer a comprehensive diagnostic tools portfolio for heart patients, Medtronic, Inc. (MDT - Analyst Report) recently launched the SEEQ Mobile Cardiac Telemetry (MCT) System in the U.S.
Minneapolis-based Medtronic is not alone when it comes to developing miniature products. St. Jude Medical Inc. purchased Nanostim Inc. last October to acquire its miniature pacemaker. Medtronic has been working on miniature devices for over a decade.
Last month, Medtronic's (NYSE: MDT ) first-quarter earnings topped consensus estimates on the top and bottom lines, as revenue rose 5% year over year to $4.27 billion and non-GAAP diluted earnings climbed 6% to $0.93 per share.
Leading medical device major Medtronic Inc.'s (MDT - Analyst Report) self-expanding CoreValve transcatheter aortic valve system recently exhibited cost efficiency in transcatheter aortic valve replacement (TAVR) procedure, according to new data ...